OBJECTIVE: The development of the Amplatzer Membranous VSD Occluder (AGA Medical
Corp, Plymouth, Minn) for closure of the perimembranous ventricular septal defect has …

BACKGROUND: Surgery for perimembranous ventricular septal defects (VSD) is widely
accepted procedure with minimal operative mortality. Recent publications have reported the …

Objective: To report the immediate and midterm results of transcatheter closure of
perimembranous ventricular septal defect (PmVSD) using the Amplatzer membranous VSD …

Two patients with perimembranous ventricular septal defects (VSDs) and inlet extension
have undergone uncomplicated transcatheter device closure using the Amplatzer …

This study reports the midterm results and experience of a single center of transcatheter
closure of perimembranous ventricular septal defect (VSD) with Amplatzer membranous …

Objectives To describe the initial world experience and mid‐term follow‐up of
perimembranous ventricular septal defect (pmVSD) closure with a newly designed occluder …

The surgical closure of membranous ventricular septal defects (VSDs) is associated with
morbidity and low mortality. Six patients with VSDs located in the membranous part of the …

There are very few published reports of the transcatheter closure of perimembranous
ventricular septal defects (PMVSDs) using the Amplatzer PMVSD occluder with encouraging …

Percutaneous closure of perimembranous ventricular septal defects (VSDs) has been
feasible, safe, and effective with the new Amplatzer membranous septal occluder. We report …

This multicenter study assessed the efficacy and safety of transcatheter closure of
perimembranous ventricular septal defect (VSD) using a modified double-disk occluder. In 5 …